Fenimore Christopher R. — SEC Form 4 filings
SEC reporting owner CIK 1697422. 7 Form 4 filings on record with FilingPulse; latest filed 2026-08-20.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-25 to 2026-08-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 16 legs across 2 filings — 10,599 shares, $11,535,582 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 2,237 shares @ $1,204.71 ($2,694,936) in REGENERON PHARMACEUTICALS, INC., filed 2024-08-29.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. (REGN) | EVP Finance CFO | 7 | — | 16 legs · 10,599 sh · $11,535,582 | 16 |
Form 4 filings — Fenimore Christopher R.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-20 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 6,283 @ $381.92 · Tax withholding (F): 4,599 @ $813.47 · Option exercise (M): 6,283 (derivative) @ $0 | EDGAR |
| 2025-12-09 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 3,027 @ $0 · Tax withholding (F): 992 @ $712.94 · Grant/award (A): 14,924 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 491 @ $730.81 | EDGAR |
| 2024-12-10 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 2,591 @ $0 · Tax withholding (F): 1,140 @ $787 · Grant/award (A): 9,979 (derivative) @ $0 | EDGAR |
| 2024-08-29 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 228 @ $1,204.79 · Sale (S): 766 @ $1,205.44 · Sale (S): 200 @ $1,206.30 · Sale (S): 2,237 @ $1,204.71 · Sale (S): 928 @ $1,205.49 · Sale (S): 450 @ $1,206.15 · +4 more | EDGAR |
| 2024-02-12 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 344 @ $950.49 · Sale (S): 487 @ $951.39 · Sale (S): 1,046 @ $952.62 · Sale (S): 1,342 @ $953.47 · Sale (S): 1,100 @ $954.57 · Sale (S): 600 @ $955 | EDGAR |
| 2024-01-25 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 5,000 @ $555.67 · Tax withholding (F): 3,986 @ $948.50 · Option exercise (M): 5,000 @ $399.66 · Tax withholding (F): 3,583 @ $948.50 · Option exercise (M): 5,000 (derivative) @ $0 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1697422 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →